跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CGRP antagonist
首页
药物
CGRP antagonist
CGRP antagonist
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
ANTAGONIST ANTIBODIES DIRECTED AGAINST CALCITONIN GENE-RELATED PEPTIDE AND METHODS USING SAME
EP 3178493 A1
申请人: LABRYS BIOLOGICS INC
优先权: 2005
CN
EP
US
24 件公开
EP 4324481 A3
申请人: TEVA PHARMACEUTICALS INT GMBH
优先权: 2014
CN
EP
US
7 件公开
US 10556945 B2
申请人: TEVA PHARMACEUTICALS INT GMBH
优先权: 2015
US
4 件公开
ACUTE TREATMENT AND RAPID TREATMENT OF HEADACHE USING ANTI-CGRP ANTIBODIES
EP 3908606 A1
申请人: H LUNDBECK AS
优先权: 2019
CN
EP
US
WO
17 件公开
TREATING REFRACTORY MIGRAINE
EP 3515937 B1
申请人: TEVA PHARMACEUTICALS INT GMBH
优先权: 2016
CN
EP
US
WO
15 件公开
COMBINATION THERAPY OF LASMIDITAN AND A CGRP ANTAGONIST FOR USE IN THE TREATMENT OF MIGRAINE
EP 3678665 A1
申请人: LILLY CO ELI
优先权: 2017
CN
EP
US
WO
7 件公开
Methods for treating visceral pain by administering antagonist antibodies directed against calcitonin gene-related peptide
US 8623366 B2
申请人: PIOS ARIEL ATES
优先权: 2009
CN
US
6 件公开
TREATMENT OF MEDICATION OVERUSE HEADACHE USING ANTI-CGRP OR ANTI-CGRP-R ANTIBODIES
EP 3908607 A4
申请人: H LUNDBECK AS
优先权: 2019
CN
EP
US
WO
5 件公开
TREATMENT OF HEADACHE USING ANTI-CGRP ANTIBODIES
EP 3962522 A4
申请人: H LUNDBECK AS
优先权: 2019
CN
EP
US
WO
5 件公开
PIPERIDINE CARBOXAMIDE AZAINDANE DERIVATIVE, METHOD FOR PREPARING SAME, AND USE THEREOF
EP 4516793 B1
申请人: BRISE PHARMACEUTICALS CO LTD
优先权: 2022
CN
EP
US
WO
4 件公开
USE OF CGRP RECEPTOR ANTAGONISTS IN TREATING GLAUCOMA
EP 4316595 A3
申请人: SOARES CHRISTOPHER J
优先权: 2016
CN
EP
US
4 件公开
CGRP antagonists
US 7807666 B2
申请人: BOEHRINGER INGELHEIM INT
优先权: 2006
CN
US
4 件公开
第 1 / 8 页
上一页
下一页
药物
反馈